This inventor holds 22 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 5 EPO patents, primarily in Biotechnology Research. Top assignees: Bristol-Myers Squibb Compnay, Archemix Corporation, Anadys Pharmaceutical, Inc.. Active years: 2001-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
16 out of 3,742 
2 out of 24 
1 out of 1 
Years Active: 2001-2024
Areas of Expertise:
Title: The Innovations of Sharon T. Cload: A Pioneer in Therapeutic Proteins
Introduction
Sharon T. Cload, based in Cambridge, MA, has made significant contributions to the field of biotechnology with a total of 22 patents to his name. His work primarily focuses on developing innovative proteins for therapeutic applications, addressing critical health issues such as cholesterol-related diseases and muscular dystrophy.
Latest Patents
One of Cload's latest inventions is the creation of fibronectin-based scaffold domain proteins that bind to PCSK9. This innovative protein plays a crucial role in the treatment of atherosclerosis, hypercholesterolemia, and other cholesterol-related diseases. Cload's work extends to cells that contain these proteins, the polynucleotides that encode them, and the vectors comprising those polynucleotides.
Another key patent involves fibronectin-based scaffold domain proteins that bind to myostatin. These proteins are designed to have therapeutic applications for various conditions, including muscular dystrophy, cachexia, sarcopenia, osteoarthritis, osteoporosis, diabetes, obesity, COPD, chronic kidney disease, heart failure, myocardial infarction, and fibrosis. As with his other patents, this invention includes cells, polynucleotides, and vectors related to the innovative proteins.
Career Highlights
Throughout his career, Sharon T. Cload has worked with prominent organizations in biotechnology, including Bristol-Myers Squibb Company and Archemix Corporation. His expertise and innovative thinking have driven forward research and development in protein therapeutics, contributing to life-changing medical advancements.
Collaborations
Collaboration has been a key aspect of Cload's work, allowing him to leverage the expertise of fellow researchers. Notable coworkers include Dasa Lipovsek and Ginger Chao Rakestraw, with whom he has partnered on various projects to enhance the scope and impact of his innovations.
Conclusion
Sharon T. Cload stands out as a pioneering inventor in the realm of therapeutic proteins. His extensive portfolio of patents reflects his dedication to advancing medical science and creating innovative solutions that address significant health challenges. As he continues his work, the potential impact of his research in the field of biotechnology remains promising.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile